Rimrock Gold Corp. (OTCPK: RMRK)
Health Care · Pharmaceuticals · US
$0.00
-33.33% today · -33.3% 1Y
Rimrock Gold Corp. (OTCPK: RMRK) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $576.81K and employs 2 people.
Over the last twelve months the share price has lost 33.3%, trading between 0.00 and 0.00.
Tweenvest scores Rimrock Gold Corp. across four factors: quality 4/100. Its strongest factor is quality.
RMRK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $576.81K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -0.06
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 2.88B
- Employees
- 2
- Next earnings
- —
About Rimrock Gold Corp.
Rimrock Gold Corp., through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts. The company was incorporated in 2007 and is based in Las Vegas, Nevada.
- ISIN
- US76676T1097
- Founded
- 2007
- Listed since
- Feb 9, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.